Yahoo!
My Yahoo!
Mail
Sign In
[New User?
Sign Up
]
Finance Home
|
Help
Wednesday, February 10, 2010, 6:38am EST - Canadian Markets open in 2 hours and 52 minutes.
To create a watchlist or portfolio of shares,
Sign-in
or
Register
Finance Home
Investing
Volume Leaders
Local Markets
US Markets
International Markets
Advances & Declines
ETFs
Income Trust News
News & Opinion
Markets
Industry
RSS-My Yahoo!
Personal Finance
Banking & Budgeting
Calculators
Insurance
Retirement
Taxes
My Portfolios
Sign In to Create/Edit My Portfolios
Get Quotes
Symbol Lookup
Exchanges
Eli Lilly & Co. (LLY)
On Feb 9:
35.20 USD
0.00 (0.00%)
MORE ON LLY
Quotes
Summary
Options
Historical Prices
Charts
Interactive
Basic Chart
Technical Chart
News & Info
Headlines
Company Events
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Major Holders
Insider Trans.
Insider Roster
Financials
Income Statement
Balance Sheets
Cash Flow
LILLY ELI CO
(NYSE:LLY) Delayed quote data
Last Trade:
35.20 USD
Trade Time:
Feb 9
Change:
0.00 (0.00%)
Prev Close:
34.71
Open:
N/A
Bid:
N/A
Ask:
N/A
1y Target Est:
58.50
Day's Range:
N/A - N/A
52wk Range:
27.21 - 38.40
Volume:
0
Avg Vol
(3m)
:
6,916,010
Market Cap:
40.45B
P/E
(ttm)
:
17.20
EPS
(ttm)
:
2.05
Div & Yield:
1.96 (5.65%)
1d
5d
3m
6m
1y
2y
5y
max
Free Annual Reports
Add LLY to Portfolio
Download Data
HEADLINES
Researchers find sex-specific lung cancer genes
at Reuters
(Tue 7:34pm)
UK court overturns GSK patent for lupus drug
at FT.com
(Tue 6:10pm)
Bone Up On This Potential Blockbuster
at Motley Fool
(Tue 11:58am)
UK court rules HGS gene patent invalid -lawyers
at Reuters
(Tue 11:39am)
Four Stock Ideas as the Market Searches for Support
at Seeking Alpha
(Tue 9:56am)
Health Care: Rx for MBA Job Blues
BusinessWeek
(Tue 8:08am)
Lechleiter pay rises in 1st full year as Lilly CEO
AP
(Mon, Feb 8)
Eli Lilly CEO's 2009 Compensation Totaled $16.4 Million
at The Wall Street Journal Online
(Mon, Feb 8)
Alkermes Retains Neutral Rec
Zacks.com
(Mon, Feb 8)
[$$] Sanofi to decide soon on reviving Merck venture
at The Wall Street Journal Online
(Sun, Feb 7)
How Big Pharma Got in This Fix
at Seeking Alpha
(Sun, Feb 7)
[$$] Research Reports
at Barrons.com
(Sat, Feb 6)
What Is The Value Of An Employee
at Investopedia
(Fri, Feb 5)
Stalled Health Care Bill Leaves Drug Makers in Regulatory Limbo
at The New York Times
(Fri, Feb 5)
More Headlines for LLY...
ANALYST
EPS Est (next year)
(Dec-08)
:
3.91
EPS Est (in 2 years)
(Dec-09)
:
4.31
Avg Rec (current)*:
2.8
PEG Ratio:
1.68
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion
-
Estimates
BUSINESS SUMMARY
Eli Lilly and Company engages in the discovery, development, manufacture, and sale of pharmaceutical products in the United States, Puerto Rico, and internationally.
Full Company Profile
Add to Portfolio
Email to a Friend
Get
Summary
for Another Symbol:
Symbol Lookup
Latest News
Canadian Indices